Skip to main content
. 2019 Dec 18;10:121. doi: 10.1186/s13244-019-0801-z

Fig. 3.

Fig. 3

Hepatocellular carcinoma (HCC) treatment options divided by modality. Locoablative therapies (PEA, RFA, MWA), transcatheter therapies (TAE, TACE, DEB-TACE, TARE) and radiation therapies (SBRT) are the most commonly used locoregional treatments for HCC treatment and are reviewed in this article